Cargando…

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2

BACKGROUND: Pseudogene-derived long non-coding RNAs (lncRNAs) have been reported to act as key regulatory factors of cancers. However, the study focused on pseudogene misato family member 2 (MSTO2P) in the occurrence and development of colorectal cancer (CRC) remains unclear. METHODS: CCK-8, colony...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Mengjun, Zhang, Xiling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961944/ https://www.ncbi.nlm.nih.gov/pubmed/35346226 http://dx.doi.org/10.1186/s12957-022-02567-5

Ejemplares similares

LncRNA GAS5 facilitates nasopharyngeal carcinoma progression through epigenetically silencing PTEN via EZH2
por: Zhao, Dan, et al.
Publicado: (2019)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression
por: Zang, Xueyan, et al.
Publicado: (2020)

Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes
por: Yang, Jiebin, et al.
Publicado: (2020)

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2
por: Lian, Yifan, et al.
Publicado: (2018)

Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2
por: Cai, Nuoya, et al.
Publicado: (2019)

EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
por: Béguelin, Wendy, et al.
Publicado: (2017)

Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma
por: Li, Bei, et al.
Publicado: (2020)

EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
por: Yi, Xiaoqing, et al.
Publicado: (2017)

LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
por: Xu, Tianwei, et al.
Publicado: (2020)

Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia
por: Zhou, Hao, et al.
Publicado: (2023)

lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2
por: Hong, Sen, et al.
Publicado: (2021)

Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells
por: Chien, Yi-Chung, et al.
Publicado: (2020)

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
por: Wang, Xin, et al.
Publicado: (2016)

LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
por: Zhang, Mingkun, et al.
Publicado: (2021)

Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types
por: Vrba, Lukas, et al.
Publicado: (2018)

LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis
por: Zhu, Hong-Yan, et al.
Publicado: (2021)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2
por: Xue, Weinan, et al.
Publicado: (2020)

TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021)

Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer
por: Su, Min, et al.
Publicado: (2018)

LncRNA SNHG6 Silencing Could Arrest Progression of High Grade Colorectal Cancers
por: Jafari-Oliayi, Amin, et al.
Publicado: (2022)

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017)

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
por: Pinton, Giulia, et al.
Publicado: (2021)

Retraction Notice to: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2
por: Hong, Sen, et al.
Publicado: (2023)

STAT3-Induced Upregulation of lncRNA CASC9 Promotes the Progression of Bladder Cancer by Interacting with EZH2 and Affecting the Expression of PTEN
por: Yuan, Bo, et al.
Publicado: (2020)

LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
por: Lu, Wei, et al.
Publicado: (2021)

Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1
por: Xue, Peng, et al.
Publicado: (2021)

LINC00565 promotes the progression of colorectal cancer by upregulating EZH2
por: Shao, Xiaxia, et al.
Publicado: (2021)

LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription
por: Xie, Xina, et al.
Publicado: (2021)

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
por: Pinton, Giulia, et al.
Publicado: (2022)

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
por: Chen, Ying, et al.
Publicado: (2018)

LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2021)

LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene
por: Zhao, Zhen, et al.
Publicado: (2021)

Novel biallelic variants in MSTO1 associated with mitochondrial myopathy
por: Schultz-Rogers, Laura, et al.
Publicado: (2019)

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
por: Kong, Yahui, et al.
Publicado: (2018)

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
por: Fei, Fan, et al.
Publicado: (2018)

Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression
por: Ding, Jie, et al.
Publicado: (2017)

LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
por: Guo, Kai, et al.
Publicado: (2021)

LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer
por: Luo, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lfuj26pr31tafp7ku521mm32m9